PRIMARY STUDY

Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis.

Key Findings:  Caryophyllene oxide, an oxygenated terpenoid, well known as preservative in food, drugs and cosmetics, has been tested in vitro as an antifungal against dermatophytes. Its antifungal activity has been compared to ciclopiroxolamine and sulconazole, commonly used in onychomycosis treatment and chosen because of their very different chemical structures.

Type of Study:  Laboratory Study

Study Result:  Positive

Study Location(s):  France

Year of Pub:  1999


Cannabinoids Studied: 

Phytocannabinoid Source:  Not Applicable

Terpenes Studied:  ß-Caryophyllene

Receptors Studied:  CB2

Dosage: 1% w/v solution

Route of Administration:  In vitro



Link to study